Sort
30,917 grants matching “tumor microenvironment”
Transformation of a human iPSC-derived bone marrow organoid for the study of hematopoiesis
$469,042Kellie Rae Machlus · Boston Children'S Hospital · R21 · FY2025 · DK
Roles of hyaluronic acid in cancer stem cell niche
$469,011Kounosuke Watabe · Wake Forest University Health Sciences · R01 · FY2016 · CA
Molecular Mechanisms of Bladder Cancer Immunometabolism
$468,881Liuqing Yang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Exploiting a novel regulator of immunometabolism to enhance immunotherapy
$468,859Edward John Usherwood · Dartmouth College · R01 · FY2024 · CA
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
$468,852Li Ding · Washington University · R01 · FY2023 · CA
Definition of Microenvironment in Breast Cancer
$468,845Mina J Bissell · University Of Calif-Lawrenc Berkeley Lab · R37 · FY2012 · CA
Neoadjuvant checkpoint blockade for recurrent glioblastoma
$468,752Robert M Prins · University Of California Los Angeles · R01 · FY2024 · CA
Acquisition of A Microfluidic Chip-Based System for Cluster Sorting and Dispensing
$468,700Charles Kf Chan · Stanford University · S10 · FY2021 · OD
Overcoming ibrutinib resistance in mantle cell lymphoma
$468,669Alexey V. Danilov · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Project 1: Identifying new therapeutic avenues to selectively target tumors with uncontrolled mTORC1 activation
$468,591David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2024 · CA
Pharmacological Blockage of XBP-1s Expression in Cancer
$468,524Juan R Del Valle · University Of South Florida · R01 · FY2015 · CA
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$468,519Jin Chen · Vanderbilt University Medical Center · R01 · FY2024 · CA
Targeting the innate immune response in HNSCC
$468,514Judith A. Varner · University Of California, San Diego · R01 · FY2019 · DE
Robust microdroplet-based mechanical probes for wide-ranging mechanobiology applications
$468,508Ellen May Sletten · University Of California Los Angeles · R01 · FY2019 · GM
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer
$468,466David D Schlaepfer · University Of California, San Diego · R01 · FY2020 · CA
Cancer cell-intrinsic mitochondrial stress responses influence protective immunity
$468,373Kyle Kristopher Payne · Rutgers Biomedical And Health Sciences · R37 · FY2025 · CA
The DARC side of Breast Cancer Disparities - African Ancestry and Cancer- Related Immune Response
$468,366Melissa B Davis · Morehouse School Of Medicine · R01 · FY2023 · CA
Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism
$468,333Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2025 · CA
Microenvironmental contribution of the Choroid Plexus and Cerebral Spinal Fluid in breast to brain metastases
$468,283Josh Neman-Ebrahim · University Of Southern California · R01 · FY2021 · CA
Microenvironmental contribution of the Choroid Plexus and Cerebral Spinal Fluid in breast to brain metastases
$468,283Josh Neman-Ebrahim · University Of Southern California · R01 · FY2022 · CA
Microenvironmental contribution of the Choroid Plexus and Cerebral Spinal Fluid in breast to brain metastases
$468,283Josh Neman-Ebrahim · University Of Southern California · R01 · FY2020 · CA
Targeting UHRF1 in combinational immunotherapy
$468,277Xiao-Fan Wang · Duke University · R01 · FY2021 · CA
Targeting the innate immune response in HNSCC
$468,267Judith A. Varner · University Of California, San Diego · R01 · FY2020 · DE
Targeting the innate immune response in HNSCC
$468,267Judith A. Varner · University Of California, San Diego · R01 · FY2021 · DE
Targeting the innate immune response in HNSCC
$468,267Judith A. Varner · University Of California, San Diego · R01 · FY2018 · DE